Tim Anderson analyst BAML

Currently out of the existing stock ratings of Tim Anderson, 37 are a BUY (38.54%), 45 are a HOLD (46.88%), 14 are a SELL (14.58%).

Tim Anderson

Work Performance Price Targets & Ratings Chart

Analyst Tim Anderson, currently employed at BAML, carries an average stock price target met ratio of 89.69% that have a potential upside of 35.22% achieved within 212 days.

Tim Anderson’s has documented 188 price targets and ratings displayed on 17 stocks. The coverage is on Industrials, Healthcare sectors.

Most recent stock forecast was given on AMGN, Amgen at 05-Aug-2026.

Wall Street Analyst Tim Anderson

Analyst best performing recommendations are on MLYS (MINERALYS THERAPEUTICS, COMMON STOCK).
The best stock recommendation documented was for MLYS (MINERALYS THERAPEUTICS, COMMON STOCK) at 8/28/2025. The price target of $43 was fulfilled within 46 days with a profit of $27.78 (182.52%) receiving and performance score of 39.68.

Average potential price target upside

HUBG Hub Group LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer ABBV AbbVie AMGN Amgen BIIB Biogen BMY Bristol-Myers Squibb Company GILD Gilead Sciences JNJ Johnson & Johnson MRNA Moderna REGN Regeneron Pharmaceuticals AZN AstraZeneca PLC ADR AMLX Amylyx Pharmaceuticals APGE Apogee Therapeutics, Common Stock MLYS Mineralys Therapeutics, Common Stock NVS Novartis AG ADR

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Jun-2022

$42

$-1.75 (-4.00%)

$50

Sell Since 02-Apr-2026

$29

$-14.75 (-33.71%)

$27

Buy Since 27-Mar-2026

$41

$-2.75 (-6.29%)

$53

Buy Since 05-Dec-2025

$35

$-8.75 (-20.00%)

$55

Hold Since 28-Jun-2021

$48

$4.25 (9.71%)

$38

Show more analysts

Please expand the browser size to see the chart

Which stock is Tim Anderson is most bullish on?

Potential upside of $-1.01 has been obtained for BMY (BRISTOL-MYERS SQUIBB COMPANY)

Which stock is Tim Anderson is most reserved on?

Potential downside of -$122.33 has been obtained for AMGN (AMGEN)

What Year was the first public recommendation made by Tim Anderson?

On 2010

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?